Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Osocimab - Bayer HealthCare

Next Previous
Drug Profile

Osocimab - Bayer HealthCare

Alternative Names: BAY-1213790; FXIa antibody

Latest Information Update: 05 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Aronora; Bayer HealthCare
  • Developer Bayer HealthCare
  • Class Antibodies; Anticoagulants; Monoclonal antibodies
  • Mechanism of Action Factor XIa inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Arterial thrombosis; Venous thromboembolism; Venous thrombosis

Most Recent Events

  • 02 Dec 2022 Discontinued - Phase-I for Arterial thrombosis in Germany (IV) (Bayer Healthcare pipeline, December 2022)
  • 02 Dec 2022 Discontinued - Phase-I for Venous thromboembolism in Belgium, USA, Portugal (IV) (Bayer Healthcare pipeline, December 2022)
  • 02 Dec 2022 Discontinued - Phase-I for Venous thrombosis in Germany (IV) (Bayer Healthcare pipeline, December 2022)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top